Real-World Adverse Events With Niraparib 200 Mg/Day Maintenance Therapy in Ovarian Cancer: A Retrospective Study

Future Oncology - United Kingdom
doi 10.2217/fon-2019-0471
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

New England Journal of Medicine
Medicine
2019English

JCSE01.10 a Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Stakeholder Perspectives on Addressing Adverse Events From Adjuvant Cancer Therapy: A Qualitative Study

Cancer
Cancer ResearchOncology
2019English

Real-World Incidence and Burden of Adverse Events Among Non-Metastatic Prostate Cancer Patients Treated With Secondary Hormonal Therapies Following Androgen Deprivation Therapy

Journal of Medical Economics
Health Policy
2020English

Real World Data and the Art of Maintenance Therapy

British Journal of Haematology
Hematology
2018English

P1.12-04 a Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Inflammatory Ocular Adverse Events With the Use of Oral Bisphosphonates: A Retrospective Cohort Study

CMAJ
Medicine
2012English

Adverse Events Encountered in Platelet Aphaeresis Procedure and Their Management: A Retrospective Study

International Blood Research & Reviews
2019English

Prediction of Ovarian Response in Women With Premature Ovarian Insufficiency Stimulated by Gonadotrophins Using Day-3 Serum Estradiol: A Retrospective Study

Journal of Gynecological Research and Obstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy